You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN--(BUSINESS WIRE)--The "Lyme Disease R&D Pipeline Analysis Report, Q4 2020" report has been added to ResearchAndMarkets.com's offering. The Q4 Lyme Disease pipeline report is part of the 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Lyme Disease, provides an update on the mechanism of action and targets, licensing and collaboration opportunities, company profiles including their business information, and market developments. The comprehensive report on the indication presents Lyme Disease disease overview, Lyme Disease types, Lyme Disease symptoms, causes, and FDA/EMA approved treatment options. The year 2020 witnessed progress in innovations and the number of pipeline agents researched for Lyme Disease indication. The report presents near-term and long-term pipeline development trends and potential insights. The report analyzes the development progress, current status, investments, partnerships, and other developments of 12 companies. Business profiles and contact details of the companies actively perusing Lyme Disease pipeline are assessed. Companies Mentioned Reasons to Buy Lyme Disease R&D Pipeline Development Phase Trends and Insights From the discovery stage of development to phase 3 development, all the potential pipeline drug candidates are analyzed in the report. Lyme Disease discovery stage, research stage, Phase 1, phase 2, Phase 3, IND enabling studies are provided in the research. Small Lyme Disease companies look for licensing and collaboration partners High R&D costs and long duration pose challenges for small companies operating in the industry. Further, the presence of large companies and stringent regulations act as barriers for Lyme Disease pipeline development companies. Accordingly, a significant portion of small companies presents potential licensing and collaboration opportunities. Lyme Disease Pipeline Market News and Developments during 2020 The Lyme Disease industry news, pipeline research, market developments including advancement in phases, pre-clinical study results, clinical trial launches, acquisitions and mergers, regulatory approvals, and others are included in the report. Scope and Coverage Highlights Key Topics Covered: 1. Table of Contents 2. Lyme Disease Pipeline Trends and Insights 2.1 Dominant Phase type of Lyme Disease Pipeline, 2020 2.2 Most focused Mechanism of Action in Lyme Disease Pipeline 2.3 Leading type of Route of Administration during 2020 2.4 Proportion of New Molecular Entities in Lyme Disease pipeline 2.5 Active Companies Developing Lyme Disease pipeline 3. Lyme Disease Disease Types, Symptoms, Causes, and Available Treatment Options 3.1 Disease Overview 3.2 Types 3.3 Symptoms 3.4 Approved Treatment Options 4. Lyme Disease Pipeline Company Trends and Insights- Business Profiles, Drug Candidates and Contacts 5. Lyme Disease Pipeline Drug Profiles 5.1 Current Status of Drug and Vaccine Candidates 5.2 Drug Snapshot 5.2.1 Drug 5.2.2 Mechanism of Action 5.2.3 Phase 5.2.4 Co-Developer 5.2.5 Originator 5.2.6 Synonym 5.2.7 Route of Administration 5.2.8 Type of Molecule 5.2.9 Orphan Drug Status 5.2.10 New Molecular Entity 5.2.11 Area 5.3 Drug Details 5.4 Mechanism of Action 5.5 Licensing/Collaboration Agreements 5.6 Clinical Trial Details 6. Lyme Disease Pipeline Market News and Developments during 2020 7. Appendix 7.1 About the Publisher 7.2 Sources and Research Methodology For more information about this report visit https://www.researchandmarkets.com/r/w0klak

Answer: Q4 2020 Lyme Disease R&D Pipeline Report - Trends, Market Analysis, and Developments - ResearchAndMarkets.com